Laura Monlezun

Laura Monlezun

Auto-generated profile, based on publicly available information

Laura Monlezun

Université Paris Cité, CNRS, Institut de Biologie Physico-Chimique, Expression Génétique Microbienne, 13 rue Pierre et Marie Curie, 75005 Paris, France

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Trends in Microbiology
Verified
Journal Article
Closed access
FCFrancesca R. Cianfanelli
Francesca R. Cianfanelli
LMLaura Monlezun
Laura Monlezun
SCSarah Coulthurst
Sarah Coulthurst

12 February 2016 in Nature Communications
Verified
Journal Article
Open access
LDLaetitia Daury
Laetitia Daury
FOFrançois Orange
François Orange
JTJean-Christophe Taveau
Jean-Christophe Taveau
AVAlice Verchère
Alice Verchère
LMLaura Monlezun
Laura Monlezun
OLOlivier Lambert
Olivier Lambert
Tripartite multidrug efflux systems of Gram-negative bacteria are composed of an inner membrane transporter, an outer membrane channel and a periplasmic adaptor protein. They are assumed to form ducts inside the periplasm facilitating drug exit across the outer membrane. Here we present the reconstitution of native Pseudomonas aeruginosa MexAB–OprM and Escherichia coli AcrAB–TolC tripartite Resistance Nodulation and cell Division (RND) efflux systems in a lipid nanodisc system. Single-particle analysis by electron microscopy reveals the inner and outer membrane protein components linked together via the periplasmic adaptor protein. This intrinsic ability of the native components to self-assemble also leads to the formation of a stable interspecies AcrA–MexB–TolC complex suggesting a common mechanism of tripartite assembly. Projection structures of all three complexes emphasize the role of the periplasmic adaptor protein as part of the exit duct with no physical interaction between the inner and outer membrane components.

1 January 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
SGSophie Guénard
Sophie Guénard
CMCédric Muller
Cédric Muller
LMLaura Monlezun
Laura Monlezun
PBPhilippe Benas
Philippe Benas
Isabelle BroutinIsabelle Broutin
Isabelle Broutin
PPPatrick Plésiat
Patrick Plésiat
Constitutive overproduction of the pump MexXY-OprM is recognized as a major cause of resistance to aminoglycosides, fluoroquinolones, and zwitterionic cephalosporins in Pseudomonas aeruginosa . In this study, 57 clonally unrelated strains recovered from non-cystic fibrosis patients were analyzed to characterize the mutations resulting in upregulation of the mexXY operon. Forty-four (77.2%) of the strains, classified as agrZ mutants were found to harbor mutations inactivating the local repressor gene ( mexZ ) of the mexXY operon ( n = 33; 57.9%) or introducing amino acid substitutions in its product, MexZ ( n = 11; 19.3%). These sequence variations, which mapped in the dimerization domain, the DNA binding domain, or the rest of the MexZ structure, mostly affected amino acid positions conserved in TetR-like regulators. The 13 remaining MexXY-OprM strains (22.8%) contained intact mexZ genes encoding wild-type MexZ proteins. Eight (14.0%) of these isolates, classified as agrW1 mutants, overexpressed the gene PA5471, which codes for the MexZ antirepressor AmrZ, with 5 strains exhibiting growth defects at 37°C and 44°C, consistent with mutations impairing ribosome activity. Interestingly, one agrW1 mutant appeared to harbor a 7-bp deletion in the coding sequence of the leader peptide, PA5471.1, involved in ribosome-dependent, translational attenuation of PA5471 expression. Finally, DNA sequencing and complementation experiments revealed that 5 (8.8%) strains, classified as agrW2 mutants, harbored single amino acid variations in the sensor histidine kinase of ParRS, a two-component system known to positively control mexXY expression. Collectively, these results demonstrate that clinical strains of P. aeruginosa exploit different regulatory circuitries to mutationally overproduce the MexXY-OprM pump and become multidrug resistant, which accounts for the high prevalence of MexXY-OprM mutants in the clinical setting.

1 October 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KEKelvin Eckert
Kelvin Eckert
JSJean-Michel Saliou
Jean-Michel Saliou
LMLaura Monlezun
Laura Monlezun
AVArmelle Vigouroux
Armelle Vigouroux
NANoureddine Atmane
Noureddine Atmane
SMSolange Moréra
Solange Moréra
Hsp90 (heat shock protein 90) is an ATP-dependent molecular chaperone regulated by collaborating proteins called cochaperones. This machinery is involved in the conformational activation of client proteins like signaling kinases, transcription factors, or ribonucleoproteins (RNP) such as telomerase. TPR (TetratricoPeptide Repeat)-containing protein associated with Hsp90 (Tah1) and protein interacting with Hsp90 (Pih1) have been identified in Saccharomyces cerevisiae as two Hsp90 cochaperones involved in chromatin remodeling complexes and small nucleolar RNP maturation. Tah1 possesses a minimal TPR domain and binds specifically to the Hsp90 C terminus, whereas Pih1 displays no homology to other protein motifs and has been involved in core RNP protein interaction. While Pih1 alone was unstable and was degraded from its N terminus, we showed that Pih1 and Tah1 form a stable heterodimeric complex that regulates Hsp90 ATPase activity. We used different biophysical approaches such as analytical ultracentrifugation, microcalorimetry, and noncovalent mass spectrometry to characterize the Pih1-Tah1 complex and its interaction with Hsp90. We showed that the Pih1-Tah1 heterodimer binds to Hsp90 with a similar affinity and the same stoichiometry as Tah1 alone. However, the Pih1-Tah1 complex antagonizes Tah1 activity on Hsp90 and inhibits the chaperone ATPase activity. We further identified the region within Pih1 responsible for interaction with Tah1 and inhibition of Hsp90, allowing us to suggest an interaction model for the Pih1-Tah1/Hsp90 complex. These results, together with previous reports, suggest a role for the Pih1-Tah1 cochaperone complex in the recruitment of client proteins such as core RNP proteins to Hsp90.

1 May 2015 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
CRCharlotte Richardot
Charlotte Richardot
PPPatrick Plésiat
Patrick Plésiat
DFDamien Fournier
Damien Fournier
LMLaura Monlezun
Laura Monlezun
Isabelle BroutinIsabelle Broutin
Isabelle Broutin
Catherine LlanesCatherine Llanes
Catherine Llanes

4 December 2020 in FEBS Letters
Verified
Journal Article
Open access
PDF file
CFCorentin R. Fostier
Corentin R. Fostier
LMLaura Monlezun
Laura Monlezun
FOFarès Ousalem
Farès Ousalem
SSShikha Singh
Shikha Singh
JHJohn F. Hunt
John F. Hunt
GBGrégory Boël
Grégory Boël
Energy‐dependent translational throttle A (EttA) from Escherichia coli is a paradigmatic ABC‐F protein that controls the first step in polypeptide elongation on the ribosome according to the cellular energy status. Biochemical and structural studies have established that ABC‐F proteins generally function as translation factors that modulate the conformation of the peptidyl transferase center upon binding to the ribosomal tRNA exit site. These factors, present in both prokaryotes and eukaryotes but not in archaea, use related molecular mechanisms to modulate protein synthesis for heterogenous purposes, ranging from antibiotic resistance and rescue of stalled ribosomes to modulation of the mammalian immune response. Here, we review the canonical studies characterizing the phylogeny, regulation, ribosome interactions, and mechanisms of action of the bacterial ABC‐F proteins, and discuss the implications of these studies for the molecular function of eukaryotic ABC‐F proteins, including the three human family members.